Tetta C, Segoloni G, Fidelio T, Licata C, Sancipriano G P, Iacono G, Ragni R, Vercellone A
Laboratorio di Immunopatologia, Università di Torino.
Minerva Urol Nefrol. 1991 Jul-Sep;43(3):181-3.
The Authors review the mechanisms involved in the production of cytokines during substitutive extracorporeal treatment with particular reference to microbial contamination and possibility of backfiltration of bacterial constituents more likely to occur with high permeability membranes. Recent and on-going studies from our laboratory support the contention that patients treated with high permeability membranes may be chronically stimulated. Use of "ultrapure" solution indeed brings about a marked reduction in predialytic plasma levels of tumor necrosis factor (TNF) in regard to what observed when standard solutions are adopted.